Literature DB >> 19480619

Prevalence of cardiomyopathy in apparently healthy cats.

Christopher F Paige1, Jonathan A Abbott, François Elvinger, R Lee Pyle.   

Abstract

OBJECTIVE: To determine the prevalence of cardiomyopathy and the relationship between cardiomyopathy and heart murmurs in apparently healthy cats.
DESIGN: Cross-sectional study. ANIMALS: 103 privately owned, apparently healthy domestic cats. PROCEDURES: Cats were physically and echocardiographically examined by 2 investigators independently. Left ventricular wall thickness was determined via 2-dimensional echocardiography in short-axis and long-axis planes. Left ventricular hypertrophy was identified when end-diastolic measurements of the interventricular septum or posterior wall were > or = 6 mm. Cats with left ventricular hypertrophy but without left ventricular dilatation were considered to have hypertrophic cardiomyopathy (HCM). The associations between heart murmurs and Doppler echocardiographic velocity profiles indicative of dynamic ventricular outflow tract obstruction were evaluated.
RESULTS: Heart murmurs were detected in 16 (15.5%; 95% confidence interval, 9.2% to 24.0%) cats; of these, 5 had cardiomyopathy. Cardiomyopathy was also identified in 16 (15.5%; 95% confidence interval, 9.2% to 24.0%) cats; 15 had HCM, and 1 had arrhythmogenic right ventricular cardiomyopathy. Of the cats with HCM, 11 had segmental left ventricular hypertrophy, 3 had diffuse left ventricular hypertrophy, and 1 had borderline left ventricular hypertrophy with marked systolic anterior motion of the mitral valve. Sensitivity and specificity of auscultatory detection of a heart murmur for diagnosing cardiomyopathy were 31% and 87%, respectively. Echocardiographic evidence of late systolic acceleration within ventricular outflow tracts was associated with the existence of a heart murmur. CONCLUSIONS AND CLINICAL RELEVANCE: Cardiomyopathy was common in the healthy cats evaluated in this study. In apparently healthy cats, detection of a heart murmur is not a reliable indicator of cardiomyopathy.

Entities:  

Mesh:

Year:  2009        PMID: 19480619     DOI: 10.2460/javma.234.11.1398

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  51 in total

1.  End-stage hypertrophic cardiomyopathy in a cat.

Authors:  Andrew J M White
Journal:  Can Vet J       Date:  2015-05       Impact factor: 1.008

2.  Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy.

Authors:  V K Yang; J E Rush; S Bhasin; A J Wagers; R T Lee
Journal:  J Vet Cardiol       Date:  2019-09-01       Impact factor: 1.701

3.  Assessment of diastolic function using mitral flow propagation velocity in cats.

Authors:  Keisuke Sugimoto; Nana Kawase; Takuma Aoki
Journal:  Can J Vet Res       Date:  2020-04       Impact factor: 1.310

Review 4.  Feline genetics: clinical applications and genetic testing.

Authors:  Leslie A Lyons
Journal:  Top Companion Anim Med       Date:  2010-11

5.  Serum microRNA profiles in cats with hypertrophic cardiomyopathy.

Authors:  K Weber; N Rostert; S Bauersachs; G Wess
Journal:  Mol Cell Biochem       Date:  2015-01-09       Impact factor: 3.396

6.  Validation of a commercial human ELISA to measure hyaluronic acid concentration in feline plasma.

Authors:  Kaela E Shaw; Alexa M Bersenas; Shane W Bateman; Shauna L Blois; R Darren Wood
Journal:  J Vet Diagn Invest       Date:  2021-09-13       Impact factor: 1.279

Review 7.  Inherited cardiomyopathies in veterinary medicine.

Authors:  Joshua A Stern; Yu Ueda
Journal:  Pflugers Arch       Date:  2018-10-03       Impact factor: 3.657

8.  Auriculectomy for spontaneous thrombosis of the left auricle in a domestic shorthair cat.

Authors:  Zachary Dvornicky-Raymond; Janis Lapsley; Valentin Janvier; Ileana Miranda; Sean McDonaugh; Galina Hayes
Journal:  Can Vet J       Date:  2020-08       Impact factor: 1.008

9.  Dual therapy with clopidogrel and rivaroxaban in cats with thromboembolic disease.

Authors:  Sara T Lo; Ashley L Walker; Catherine J Georges; Ronald Hl Li; Joshua A Stern
Journal:  J Feline Med Surg       Date:  2021-05-10       Impact factor: 2.015

10.  A genetic polymorphism in P2RY1 impacts response to clopidogrel in cats with hypertrophic cardiomyopathy.

Authors:  Yu Ueda; Ronald H L Li; Nghi Nguyen; Eric S Ontiveros; Samantha L Kovacs; Maureen S Oldach; Karen M Vernau; Michael H Court; Joshua A Stern
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.